Metaxalone
- Product NDC
- 70518-2275
- 11-digit product format
- 705182275
- Labeler code
- 70518
- Product ID
- 70518-2275_c7a378c8-7836-6ccc-e053-2995a90a5e11
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Metaxalone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA208774
- Marketing category
- ANDA
- Marketing start
- 2019-08-21
- Marketing end
- 0000-00-00
- Substance
- METAXALONE
- Active strength
- 800 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2275-0 | 70518227500 | 90 TABLET in 1 BOTTLE, PLASTIC (70518-2275-0) | 90 tablet | 2019-08-21 | 0000-00-00 | No | No | Current |
| 70518-2275-1 | 70518227501 | 60 TABLET in 1 BOTTLE, PLASTIC (70518-2275-1) | 60 tablet | 2019-10-02 | 0000-00-00 | No | No | Current |
| 70518-2275-2 | 70518227502 | 30 TABLET in 1 BOTTLE, PLASTIC (70518-2275-2) | 30 tablet | 2019-10-02 | 0000-00-00 | No | No | Current |